TILT Biotherapeutics (private company)
TILT Biotherapeutics Ltd is a preclinical stage company working in the field of cancer immunotherapy. TILT aims to translate its unique approach into clinical trials.
The company’s patented technology involves utilization of oncolytic viruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR) and checkpoint inhibiting antibody therapy.
The TILT approach has the potential to achieve similar results in CAR therapy of solid tumors as currently achieved for CD19+ hematological tumors.
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investments 15.69M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to TILT Biotherapeutics
| Name | Criteria | |
|---|---|---|
 |
Oura Health
60%
|
|
|
Synoste Oy
60%
|
|
|
Solar Foods
50%
|
|
|
Valkee
50%
|
|
 |
Abzena
48%
|
|
|
Achilles Therapeutics
48%
|
|
 |
Adrenomed AG
48%
|
|
 |
AFYX Therapeutics
48%
|
|
 |
Algenex
48%
|
|
 |
Alvotech
48%
|
|
Belgium
Netherlands
Austria
Switzerland
Estonia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal